Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Clazakizumab by CSL for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD): Likelihood of Approval
Clazakizumab is under clinical development by CSL and currently in Phase III for End-Stage Kidney Disease (End-Stage Renal Disease or...